Preference for a new prefilled insulin pen compared with the original pen

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Medical Research and Opinion

• Publication date

  2011-10-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/03007995.2011.630721PMID 21988614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonparametric Statistics for the Behavioral Sciences

  2022cited by this paper
• Insulin Aspart

  2012cited by this paper
• Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses

  2011cited by this paper
• Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals

  2011cited by this paper
• Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe

  2010cited by this paper
• Prevalence of diabetes among men and women in China.

  2010cited by this paper
• Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease

  2010cited by this paper
• Reusable and Disposable Insulin Pens for the Treatment of Diabetes: Understanding the Global Differences in User Preference and an Evaluation of Inpatient Insulin Pen Use

  2010cited by this paper
• Prevalence of diabetes among men and women in China.

  2010cited by this paper
• A Comparison of the Handling and Accuracy of Syringe and Vial Versus Prefilled Insulin Pen (FlexPen)

  2009cited by this paper
• Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.

  2008influential reference
• Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.

  2008cited by this paper
• Insulin Pen—The “iPod” for Insulin Delivery (Why Pen Wins over Syringe)

  2008cited by this paper
• Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.

  2008cited by this paper
• Prefilled insulin device with reduced injection force: patient perception and accuracy

  2008cited by this paper
• A simulation approach on Cronbach's alpha statistical significance

  2007cited by this paper
• Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes

  2007cited by this paper
• Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study.

  2005cited by this paper
• Development and validation of the insulin treatment satisfaction questionnaire.

  2004cited by this paper
• Preference for insulin delivery systems among current insulin users and nonusers.

  2004cited by this paper
• Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies.

  2004cited by this paper
• Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.

  2004cited by this paper
• A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.

  2003cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Practical statistics for medical research

  1990cited by this paper
• Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations.

  1990cited by this paper
• A Multiple Injection Regimen using an Insulin Injection Pen and Pre‐filled Cartridged Soluble Human Insulin in Adolescents with Diabetes

  1985cited by this paper
• Coefficient alpha and the internal structure of tests

  1951cited by this paper

• Decreasing patient-reported burden of treatment: A systematic review of quantitative interventional studies.

  2021cites this paper
• Patient‐reported outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes

  2020cites this paper
• RECENT ADVANCED INSULIN DELIVERY METHOD FOR FUTURE *

  2020cites this paper
• Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India

  2020cites this paper
• Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes

  2019cites this paper
• FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions

  2017cites this paper
• Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

  2017cites this paper
• Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature

  2017cites this paper
• Insulin delivery methods: Past, present and future

  2016cites this paper
• A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration

  2016cites this paper
• An Open-label Longitudinal Study on the Efficacy of Switching from Insulin Glargine or Detemir to Degludec in Type 2 Diabetes Mellitus.

  2015cites this paper
• Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus

  2015cites this paper
• Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)

  2013cites this paper
• FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals

  2012cites this paper
• Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens

  2012influential citation
• Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe

  2012cites this paper